TNDM Tandem Diabetes Care, Inc.

NASDAQ
$16.80

Tandem Diabetes Care, Inc. (TNDM) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.1% since its last earnings release on November 5, 2026.

Tandem Diabetes Care Beat Consensus Estimates, Reaffirms Revenue Guidance
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.08
Rev est $305.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $18.10

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company’s flagship product is the t:slim Insulin Delivery System.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.